Inventor
KUNZER AARON R
US35 patents
⚠️ This page may combine multiple inventors who share the name “KUNZER AARON R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
19 patentsUS9174982B2Nov 3, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC38 citations98
US9315488B2Apr 19, 2016
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC13 citations92
US8952157B2Feb 10, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC22 citations91
US9303025B2Apr 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC11 citations84
US9125913B2Sep 8, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC10 citations84
US9072748B2Jul 7, 2015
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US8940737B2Jan 27, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC7 citations83
US10676485B2Jun 9, 2020
Macrocyclic MCL-1 inhibitors and methods of use
ABBVIE INC2 citations73
US11897864B2Feb 13, 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US11786519B2Oct 17, 2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US9844547B2Dec 19, 2017
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC1 citations62
US9266877B2Feb 23, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC2 citations62
US9227963B2Jan 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC2 citations62
US8889675B2Nov 18, 2014
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC3 citations62
US9493431B2Nov 15, 2016
Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations52
US9359296B2Jun 7, 2016
7-substituted indole Mcl-1 inhibitors
ABBVIE INC1 citations52
US9156856B2Oct 13, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations52
US9035047B2May 19, 2015
7-substituted indole Mcl-1 inhibitors
ABBVIE INC1 citations52
US9877958B2Jan 30, 2018
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC1 citations51
ABBOTT LAB
9 patentsUS7390799B2Jun 24, 2008
Apoptosis promoters
ABBOTT LAB331 citations98
US7709467B2May 4, 2010
Apoptosis promoters
ABBOTT LAB50 citations97
US7504512B2Mar 17, 2009
N-acylsulfonamide apoptosis promoters
ABBOTT LAB58 citations97
US6720338B2Apr 13, 2004
N-acylsulfonamide apoptosis promoters
ABBOTT LAB98 citations97
US8343967B2Jan 1, 2013
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBOTT LAB32 citations92
US7906505B2Mar 15, 2011
Apoptosis promoters
ABBOTT LAB18 citations92
US7754886B2Jul 13, 2010
N-acylsulfonamide apoptosis promoters
ABBOTT LAB34 citations90
US7981888B2Jul 19, 2011
1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives
ABBOTT LAB8 citations84
US7910742B2Mar 22, 2011
Survivin inhibitors
ABBOTT LAB9 citations82
BRUNCKO MILAN
3 patentsUS8586754B2Nov 19, 2013
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN59 citations97
US8546399B2Oct 1, 2013
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
BRUNCKO MILAN100 citations97
US8084607B2Dec 27, 2011
Apoptosis promoters
BRUNCKO MILAN43 citations93